Literature DB >> 8904780

The serotonin transporter is a potential susceptibility factor for bipolar affective disorder.

D A Collier1, M J Arranz, P Sham, S Battersby, H Vallada, P Gill, K J Aitchison, M Sodhi, T Li, G W Roberts, B Smith, J Morton, R M Murray, D Smith, G Kirov.   

Abstract

The serotonin transporter is a strong candidate for aetiological involvement in affective disorders and psychosis. We analysed a VNTR in intron 2 of the human serotonin transporter gene (hSERT) for allelic association with bipolar affective disorder, unipolar depression and schizophrenia. An increased frequency of allele 12 of the VNTR was observed in subjects with bipolar affective disorder (n = 191; chi 2 p = 0.00048 by allele) but not unipolar depression (n = 86; chi 2 p = 0.18, ns) or schizophrenia (n = 129; chi 2 p = 0.08, ns), although a trend towards an excess of allele 12 was observed for the latter. There was also a significant difference in the frequency of allele 12 between bipolar affective disorder and unipolar depression (p = 0.0087). The relative risk for bipolar affective disorder with respect to allele 12 was 1.84 (95% CI 0.97-3.56) for heterozygotes, and 3.10 (95% CI 1.60-6.07) for homozygotes, with evidence for a gene-dosage effect. Because allele 12 is common in the population, the attributable risk is 50.8% (95% CI 14.5%-73.3%). We hypothesize that either the VNTR affects regulation of expression of hSERT at the transcriptional level or it is in linkage disequilibrium with another functional polymorphism in the gene, and this results in an increased risk for the development of bipolar affective disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904780     DOI: 10.1097/00001756-199607080-00030

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

1.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

2.  A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder.

Authors:  Jonathan Savitz; Lize van der Merwe; Mark Solms; Rajkumar Ramesar
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

3.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

4.  Genetic association studies in psychiatry. Are we putting the cart before the horse?

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

Review 5.  Association between the serotonin transporter gene and affective disorder: the evidence so far.

Authors:  A D Ogilvie; A J Harmar
Journal:  Mol Med       Date:  1997-02       Impact factor: 6.354

6.  A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo.

Authors:  A MacKenzie; J Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  Using genetic analyses to clarify the distinction between depressive and anxious symptoms in children.

Authors:  T C Eley; J Stevenson
Journal:  J Abnorm Child Psychol       Date:  1999-04

8.  Control of ion selectivity in LeuT: two Na+ binding sites with two different mechanisms.

Authors:  Sergei Y Noskov; Benoît Roux
Journal:  J Mol Biol       Date:  2008-01-15       Impact factor: 5.469

Review 9.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

10.  Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.

Authors:  A Yeo; P Boyd; S Lumsden; T Saunders; A Handley; M Stubbins; A Knaggs; S Asquith; I Taylor; B Bahari; N Crocker; R Rallan; S Varsani; D Montgomery; D H Alpers; G E Dukes; I Purvis; G A Hicks
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.